SCHEMBL25922234

SCHEMBL25922234

CCOC(O)Cc1ccc2nc(NC(=O)CC(C)(C)C)n(-c3ccc(F)cc3)c2c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KCNQ2 O43526 2/20 0.33
▸ KCNQ3 O43525 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ CSNK1D P48730 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ CASP3 P42574 1/20 0.30
▸ SENP8 Q96LD8 1/20 0.30
▸ SENP7 Q9BQF6 1/20 0.30
▸ SENP6 Q9GZR1 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ HTR7 P34969 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30659085 0.85 POLB (0.39) HPGDMEN1KMT2AL3MBTL1MAPT
SCHEMBL17583023 0.85 POLB (0.39) HPGDMEN1KMT2AL3MBTL1MAPT
SCHEMBL17583057 0.83 HPGD (0.36) NR3C1HPGDKCNQ2KCNQ3MEN1
SCHEMBL20110771 0.78 POLB (0.38) HPGDMEN1KMT2AL3MBTL1MAPT
SCHEMBL21148132 0.76 CSNK1D (0.33) MAPTCSNK1D
SCHEMBL21580986 0.73 POLB (0.38) HPGDMEN1KMT2AMAPTPOLB
SCHEMBL17582768 0.72 ALDH1A1 (0.34) HPGDMEN1KMT2ARAB9AL3MBTL1
SCHEMBL20209791 0.72 EGFR (0.34) CSNK1DTSHR
SCHEMBL16084486 0.71 KCNQ2 (0.39) NR3C1HPGDKCNQ2KCNQ3MEN1
SCHEMBL19276270 0.70 KCNQ2 (0.39) NR3C1HPGDKCNQ2KCNQ3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289822-A2 BENZOIMIDAZOL-1,2-YL AMIDES AS KV7 CHANNEL ACTIVATORS Biohaven Therapeutics Ltd. (US) 2023-12-13 — — EP disclosed
EP-3572405-B1 BENZOIMIDAZOL-1,2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KNOPP BIOSCIENCES LLC (US) 2023-07-26 — — EP disclosed
Send feedback